Anne Wojcicki, co-founder and former CEO of 23andMe, is set to regain control of the DNA-testing company after a nonprofit ...

Teva collaboration agreement aims to accelerate clinical data generation for TEV-56278 and develop Anti-PD1-IL2 Therapy.

Ecolab has launched a new resin designed to help achieve cost savings and optimize operations throughout the antibody ...

Nuvation Bio Inc., a global oncology company, received U.S. Food and Drug Administration (FDA) approval of Ibtrozi ...

Merck also introduces the first perioperative anti-PD-1 treatment regimen for adults with resectable locally advanced head ...

Novo Nordisk and Deep Apple Therapeutics Inc. have entered a research collaboration and exclusive license agreement.

According to Fortune Business Insights, the global contract research organization (CRO) services market size was valued at ...

The research program will combine Debiopharm’s AbYlink conjugation technology with Alkyon’s modular antibody platform and ...

The collaboration aims to advance the discovery and development of novel oral candidates.

OncoACP3 is a small molecule ligand with high affinity and specificity for Acid Phosphatase 3 (ACP3), a novel target in ...

PL BioScience GmbH, a German life science company, has appointed Oliver Dick, PhD, as Chief Technology Officer.

Over the past decade, the emergence of advanced therapy medicinal products (ATMPs) has fundamentally changed the approach to ...